ITGB1 Antikörper
Kurzübersicht für ITGB1 Antikörper (ABIN2479788)
Target
Alle ITGB1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Kreuzreaktivität
- Nerz
-
Produktmerkmale
- Purified IgG
-
Aufreinigung
- Purified
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1.0 mg/mL
-
-
-
: "Ultra-rapid activation of TRPV4 ion channels by mechanical forces applied to cell surface beta1 integrins." in: Integrative biology : quantitative biosciences from nano to macro, Vol. 2, Issue 9, pp. 435-42, (2010) (PubMed).
: "Compact spheroid formation by ovarian cancer cells is associated with contractile behavior and an invasive phenotype." in: International journal of cancer. Journal international du cancer, Vol. 124, Issue 9, pp. 2060-70, (2009) (PubMed).
-
: "Ultra-rapid activation of TRPV4 ion channels by mechanical forces applied to cell surface beta1 integrins." in: Integrative biology : quantitative biosciences from nano to macro, Vol. 2, Issue 9, pp. 435-42, (2010) (PubMed).
-
- ITGB1 (Integrin beta 1 (ITGB1))
-
Andere Bezeichnung
- CD29
-
Hintergrund
- Synonyms: INTEGRIN BETA 1 CHAIN
-
Gen-ID
- 3688
-
UniProt
- P05556
-
Pathways
- Cell-Cell Junction Organization, Regulation of G-Protein Coupled Receptor Protein Signaling, CXCR4-mediated Signaling Events, Signaling of Hepatocyte Growth Factor Receptor, Integrin Complex, SARS-CoV-2 Protein Interaktom
Target
-